John W Huffman Selected Research

(6aR,10aR)- 3- (1- methansulfonylamino- 4- hexyn- 6- yl)6a,7,10,10a- tetrahydro- 6,6,9- trimethyl- 6H- dibenzo(b,d)pyran

1/2011

Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John W Huffman Research Topics

Disease

4	Hypothermia 02/2014 - 10/2002
2	Glioma (Gliomas) 03/2003 - 01/2003
2	Neoplasms (Cancer) 03/2003 - 01/2003
1	Pain (Aches) 10/2021
1	Catalepsy 02/2014
1	Substance-Related Disorders (Drug Abuse) 06/2012
1	Atherosclerosis 10/2007
1	Ischemia 06/2007

Drug/Important Bio-Agent (IBA)

5	CannabinoidsIBA 02/2014 - 10/2002
2	Cannabinoid Receptor AgonistsIBA 06/2012 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2003 - 01/2003
2	Angiopoietin-2IBA 03/2003 - 01/2003
1	pravadolineIBA 10/2021
1	(6aR,10aR)- 3- (1- methansulfonylamino- 4- hexyn- 6- yl)6a,7,10,10a- tetrahydro- 6,6,9- trimethyl- 6H- dibenzo(b,d)pyranIBA 01/2011
1	SulfonamidesIBA 01/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2007
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2003
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2003
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2003
1	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 01/2003
1	Epidermal Growth Factor (EGF)IBA 01/2003

Therapy/Procedure

2	Therapeutics 03/2003 - 01/2003
1	Transplantation 06/2007